Tag Archive for USANA Health Sciences

USANA Announces Launch of Rise Wellness Protein Pop™ Plus at Costco Stores Nationwide

The brand expands its Protein Pop™ line with a carbonated, clear protein beverage delivering 30 grams of protein per can. 
Salt Lake City, UT – Rise Wellness, a wholly owned subsidiary of USANA Health Sciences, Inc. (NYSE: USNA), announced the expansion of its Protein Pop™ offering, with the launch of Protein Pop™ Plus, a new carbonated, ready‑to‑drink clear protein beverage now available at all 607 Costco locations across the United States. Protein Pop Plus builds on the success of the brand’s original Protein Pop line, offering consumers a bold new way to enjoy high‑protein nutrition in a refreshing, carbonated format.
Protein Pop Plus delivers 30 grams of protein in a 12‑ounce can, combining a blend of whey protein isolate plus bovine collagen into a clear, lightly carbonated beverage designed to drink more like a soda than a traditional protein shake. With zero sugar, no artificial sweeteners, and no caffeine, Protein Pop Plus is positioned as a satisfying alternative for consumers seeking functional nutrition without heaviness or compromise.

“Protein Pop Plus represents the next evolution of our Protein Pop brand,”

said Darin Perry, CEO of Rise Wellness.

“It’s the only clear protein drink in the market with 30 grams of protein, collagen and no artificial sweeteners.

Read more...

USANA Executive Chairman and CEO Kevin Guest on Self-Renewal Day: Strategic Growth With Six Steps

Salt Lake City, Utah – As organizations face rapid market disruption and evolving leadership demands, Self-Renewal Day (February 2nd) is a pivotal time of year for business leaders to recalibrate strategies and personal development.

“Growth does not happen by accident; it happens by choice,”

said  Kevin Guest, Executive Chairman & CEO at USANA Health Sciences (NYSE: USNA).

“Self-Renewal Day is designed to prompt people to evaluate their lives, challenge complacency, and take deliberate steps toward personal and professional renewal.”

This annual observance is a critical reminder that sustained corporate success and operational advancement begin with the individual leader’s commitment to breaking free from the status quo.

“Comfort is seductive,”

said Guest, who is also the author of the bestseller, All the Right Reasons: 12 Principles for Living a Life in Harmony.

“But nothing meaningful grows there.”

His message is clear. Renewal requires movement. It requires courage. It requires choosing long-term fulfillment over short-term ease.
One of the most powerful examples Guest shares is his decision to walk away from a lifelong dream of becoming a full-time rock musician. Music was his passion. He had talent. He had momentum. But he felt a deeper pull toward leadership, service, and building something that would impact lives at scale.

“That choice was not easy.

Read more...

USANA Health Sciences Provides Preliminary Fiscal Year 2025 Net Sales and Issues Initial Fiscal Year 2026 Net Sales Outlook

Salt Lake City, Utah – USANA Health Sciences, Inc. (NYSE: USNA) announced preliminary fiscal year 2025 net sales and initial net sales guidance for fiscal year 2026 ahead of its presentation at the 28th Annual ICR Conference. At the conference, Doug Hekking, CFO, and Walter Noot, COO, will discuss USANA’s strategy, including the Company’s initial fiscal year 2026 sales outlook.
Preliminary Fiscal Year 2025 Net Sales Results
The Company currently anticipates fiscal year 2025 consolidated net sales of approximately $925 million, ahead of its most recently issued guidance of approximately $920 million.
Initial Fiscal Year 2026 Net Sales Outlook
The Company is issuing its initial net sales outlook for fiscal year 2026 in the range of $925 million to $1.0 billion.
The Company’s initial fiscal 2026 net sales outlook reflects:

Net sales from USANA, our core nutritional business, of $720 to $765 million (compared to preliminary net sales for fiscal 2025 of approximately $777 million);
Net sales from Hiya of $140 to $155 million (compared to preliminary net sales for fiscal 2025 of approximately $132 million);
Net sales from Rise Wellness of $65 to $80 million (compared to preliminary net sales for fiscal 2025 of approximately $16 million); and
Fiscal 2026 is a 52-week year, one week less of net

Read more...

Kevin Guest Returns to USANA Health Sciences as CEO

Salt Lake City, Utah – USANA Health Sciences, Inc. (NYSE: USNA) announced today a leadership transition as part of the Company’s ongoing commitment to accelerating growth and enhancing shareholder value. Kevin Guest is returning to lead the Company as Chief Executive Officer, effective immediately. Mr. Guest, who has spent more than three decades at the Company, including eight years as CEO and the last three years as Executive Chairman, has agreed to again serve as USANA’s CEO and will continue serving as Chairman. Mr. Guest succeeds Jim Brown, who has stepped down from his position of CEO and President.

“We thank Jim for his contributions and his leadership over the past 19 years and in his role as CEO over the past 3 years,”

said Gilbert Fuller, lead independent director of the Board.

“As USANA enters its next phase, the Board believes this transition will position the Company to accelerate strategic priorities that meaningfully contribute to long-term growth opportunities.”
“Kevin has the full support of the Board and the Company’s senior leadership team. He also has good relationships with the Company’s sales force and brings a combination of deep sales, organizational and strategic experience,”

continued Mr. Fuller.

“I am truly energized to return to

Read more...

USANA’s Kevin Guest Calls for a “Great Re-Engagement” Rooted in Trust, Empathy, Purpose

As business leaders worldwide focus on re-energizing workforces after years of upheaval, Kevin Guest, Executive Chairman of USANA Health Sciences (NYSE: USNA), is urging CEOs to lead with renewed authenticity, empathy, and moral clarity—principles he calls “the real foundation of sustainable success.”

“No doubt, technology and strategy will always matter,”

Guest said.

“But what truly binds a company together is trust. When people feel seen, valued, and inspired, they do their best work, and that’s how you create a culture that thrives through any storm.”

Guest’s comments align with a growing leadership movement that emphasizes employee well-being, personalized experiences, and transparent communication. As CEOs champion what many call the “great re-engagement,” Guest believes the key lies not in new perks or digital platforms, but in timeless human connection.

“The best leaders don’t just talk about values; they live them,”

Guest said.

“Every decision should be made for all the right reasons, not just the convenient ones.”

All the Right Reasons: 12 Timeless Principles for Living a Life in Harmony, by USANA CEO and chairman Kevin Guest (PRNewsfoto/USANA)
A Leader Guided by Principle and Purpose
In his bestselling book, All the Right Reasons: 12 Timeless Principles for Living a Life in Harmony, Guest draws on his personal experiences—from rebuilding after loss to navigating corporate

Read more...

USANA Health Sciences Sales Up 3% To $262 Million

USANA Health Sciences, Inc. today announced financial results for its fiscal third quarter ended September 30, 2017.
For the third quarter of 2017, net sales were $261.8 million compared with $254.2 million in the prior-year period, or a 3.0% increase year-over-year.
There was no meaningful year-over-year impact from changes in currency exchange rates on quarterly net sales. The Company’s total number of active Customers increased by 2.4% year-over-year to 563,000.
Net earnings for the third quarter were $23.8 million compared with $30.1 million during the prior-year period, a decrease of 21.0%. Higher SG&A expense and a higher effective tax rate reduced net earnings during the quarter as they have throughout 2017.
Earnings per diluted share for the third quarter were $0.97 compared with $1.20 in the prior year period, a decrease of 19.2%. The expense related to China and the Company’s internal investigation into its China operations, which was disclosed in February 2017, negatively impacted the third quarter by approximately $1.9 million and earnings per diluted share by $0.05.
Weighted average diluted shares outstanding were 24.6 million for the third quarter of 2017, compared with 25.1 million in the prior-year period. The Company repurchased 865 thousand shares during the quarter for a total investment of

Read more...